Long-Term Follow-Up for Mortality and Cancer in a Randomized Placebo-Controlled Trial of Vitamin D3 and/or Calcium (RECORD Trial)

被引:195
作者
Avenell, Alison [1 ]
MacLennan, Graeme S. [1 ]
Jenkinson, David J. [1 ]
McPherson, Gladys C. [1 ]
McDonald, Alison M. [1 ]
Pant, Puspa R. [1 ]
Grant, Adrian M. [1 ]
Campbell, Marion K. [1 ]
Anderson, Frazer H. [2 ]
Cooper, Cyrus [3 ]
Francis, Roger M. [4 ]
Gillespie, William J. [5 ]
Robinson, C. Michael [6 ]
Torgerson, David J. [7 ]
Wallace, W. Angus [8 ]
机构
[1] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland
[2] Univ Southampton, Div Res, Southampton SO16 6YD, Hants, England
[3] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England
[4] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[5] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England
[6] Royal Infirm, Edinburgh EH3 9HB, Midlothian, Scotland
[7] Univ York, York Trials Unit, York YO10 5DD, N Yorkshire, England
[8] Univ Nottingham, Nottingham NG7 2UH, England
基金
英国医学研究理事会;
关键词
SERUM 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; BLOOD-PRESSURE; RISK; FRACTURES; REANALYSIS; PREVENTION; WOMEN; MEN;
D O I
10.1210/jc.2011-1309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Vitamin D or calcium supplementation may have effects on vascular disease and cancer. Objective: Our objective was to investigate whether vitamin D or calcium supplementation affects mortality, vascular disease, and cancer in older people. Design and Setting: The study included long-term follow-up of participants in a two by two factorial, randomized controlled trial from 21 orthopedic centers in the United Kingdom. Participants: Participants were 5292 people (85% women) aged at least 70 yr with previous low-trauma fracture. Interventions: Participants were randomly allocated to daily vitamin D-3 (800 IU), calcium (1000 mg), both, or placebo for 24-62 months, with a follow-up of 3 yr after intervention. Main Outcome Measures: All-cause mortality, vascular disease mortality, cancer mortality, and cancer incidence were evaluated. Results: In intention-to-treat analyses, mortality [hazard ratio (HR) = 0.93; 95% confidence interval (CI) = 0.85-1.02], vascular disease mortality (HR = 0.91; 95% CI = 0.79-1.05), cancer mortality (HR = 0.85; 95% CI = 0.68-1.06), and cancer incidence (HR = 1.07; 95% CI = 0.92-1.25) did not differ significantly between participants allocated vitamin D and those not. All-cause mortality (HR = 1.03; 95% CI = 0.94-1.13), vascular disease mortality (HR = 1.07; 95% CI = 0.92-1.24), cancer mortality (HR = 1.13; 95% CI = 0.91-1.40), and cancer incidence (HR = 1.06; 95% CI = 0.91-1.23) also did not differ significantly between participants allocated calcium and those not. In a post hoc statistical analysis adjusting for compliance, thus with fewer participants, trends for reduced mortality with vitamin D and increased mortality with calcium were accentuated, although all results remain nonsignificant. Conclusions: Daily vitamin D or calcium supplementation did not affect mortality, vascular disease, cancer mortality, or cancer incidence. (J Clin Endocrinol Metab 97: 614-622, 2012)
引用
收藏
页码:614 / 622
页数:9
相关论文
共 38 条
[1]  
[Anonymous], 2011, DIETARY REFERENCE IN
[2]  
[Anonymous], [No title captured]
[3]   Vitamin D supplementation and total mortality - A meta-analysis of randomized controlled trials [J].
Autier, Philippe ;
Gandini, Sara .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) :1730-1737
[4]  
Avenell Alison, 2004, Clin Trials, V1, P490, DOI 10.1191/1740774504cn053oa
[5]   Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438) [J].
Avenell, Alison ;
Cook, Jonathan A. ;
MacLennan, Graeme S. ;
McPherson, Gladys C. .
AGE AND AGEING, 2009, 38 (05) :606-609
[6]   Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes [J].
Bischoff-Ferrari, Heike A. ;
Giovannucci, Edward ;
Willett, Walter C. ;
Dietrich, Thomas ;
Dawson-Hughes, Bess .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (01) :18-28
[7]   Vitamin D supplementation for prevention of mortality in adults [J].
Bjelakovic, Goran ;
Gluud, Lise Lotte ;
Nikolova, Dimitrinka ;
Whitfield, Kate ;
Wetterslev, Jorn ;
Simonetti, Rosa G. ;
Bjelakovic, Marija ;
Gluud, Christian .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07)
[8]   Calcium supplementation and cancer incidence [J].
Bolland, Mark J. ;
Reid, Ian R. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (03) :792-793
[9]   Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis [J].
Bolland, Mark J. ;
Grey, Andrew ;
Avenell, Alison ;
Gamble, Greg D. ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[10]   Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis [J].
Bolland, Mark J. ;
Avenell, Alison ;
Baron, John A. ;
Grey, Andrew ;
MacLennan, Graeme S. ;
Gamble, Greg D. ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :289